US Stock MarketDetailed Quotes

PSTV Plus Therapeutics

Watchlist
  • 1.4400
  • +0.0300+2.13%
Close Oct 18 16:00 ET
  • 1.4489
  • +0.0089+0.62%
Post 17:14 ET
8.49MMarket Cap-466P/E (TTM)

Plus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Plus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.237M--
--2024/Q3-- / 1.137M--
Aug 14, 20242024/Q21.279M / 1.117M--
May 15, 20242024/Q11.677M / 1.688M--
Mar 5, 20242023/Q41.313M / 850.670K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.237M--
--2024/Q3-- / 1.137M--
Aug 14, 20242024/Q21.279M / 1.117M--
May 15, 20242024/Q11.677M / 1.688M--
Mar 5, 20242023/Q41.313M / 850.670K--

Unlock Free Earnings Estimates

Plus Therapeutics Earnings Reports

  • Plus Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14 16:36 ET

  • Plus Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 15 16:12 ET

  • Plus Therapeutics | 10-K: FY2023 Annual Report

    Mar 5 16:03 ET

  • Plus Therapeutics | 10-Q: Q3 2023 Earnings Report

    Oct 31, 2023 16:02 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 20, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data